MMF and calcineurin taper in recurrent hepatitis C after liver transplantation: impact on histological course.

Abstract

Hepatitis C virus (HCV) recurrence after orthotopic liver transplantation (OLT) is almost universal. The optimal immunosuppression for these patients is still under discussion. We designed a retrospective case-control study to evaluate the effect of mycophenolate mofetil (MMF) treatment in patients with recurrent hepatitis C. Forty patients with… (More)

Topics

Cite this paper

@article{Bahra2005MMFAC, title={MMF and calcineurin taper in recurrent hepatitis C after liver transplantation: impact on histological course.}, author={Marcus Bahra and Ulf Peter Neumann and Dietmar Aldrich Jacob and Gero Puhl and Jochen Klupp and Jan Michael Langrehr and Thomas Berg and Peter Neuhaus}, journal={American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons}, year={2005}, volume={5 2}, pages={406-11} }